Europe — EMA
Nesivine Baby Sine Conservans (Oxymetazoline Hydrochloride)
GNH USA supplies Nesivine Baby Sine Conservans (Oxymetazoline), a nasal decongestant for relief of congestion due to colds or allergies.
Request sourcing
What is Oxymetazoline Hydrochloride?
Oxymetazoline Hydrochloride, the active ingredient in Nesivine Baby Sine Conservans, is an alpha‑adrenergic agonist presented as a nasal spray formulation for intranasal use. It provides temporary relief of nasal congestion associated with colds, sinusitis, or allergic rhinitis, and is intended for use in children and adults as directed.
GNH USA supplies Nesivine Baby Sine Conservans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets EU regulatory standards and is packaged for safe distribution.
What is Oxymetazoline Hydrochloride used for?
Oxymetazoline Hydrochloride acts on the nasal vasculature to reduce swelling and improve airflow. - Common cold: alleviates nasal blockage caused by viral upper‑respiratory infection. - Allergic rhinitis: decreases congestion due to seasonal or perennial allergens. - Sinusitis: helps relieve nasal obstruction associated with sinus inflammation.
What are the side effects of Oxymetazoline Hydrochloride?
The following adverse reactions have been reported with intranasal oxymetazoline use.
Common Side Effects: - Nasal irritation or burning sensation. - Sneezing. - Dryness of the nasal mucosa. - Headache. - Mild epistaxis (nosebleed). - Transient taste disturbance.
Serious or Rare Side Effects: - Rebound congestion with prolonged use. - Hypertension or elevated blood pressure. - Cardiac arrhythmias. - Severe allergic reaction (anaphylaxis). - Persistent nasal ulceration. - Central nervous system effects such as dizziness or tremor.
What precautions apply to Oxymetazoline Hydrochloride?
Before using Nesivine Baby Sine Conservans, consider the following safety measures. - Age restriction: avoid use in children under the age specified on the label. - Duration limit: do not exceed the recommended treatment period (typically 3‑5 days) to prevent rebound congestion. - Cardiovascular conditions: use with caution in patients with hypertension, coronary artery disease, or arrhythmias. - Drug interactions: consult a healthcare professional if taking monoamine oxidase inhibitors or other vasoconstrictors. - Pregnancy and lactation: discuss use with a physician as safety data are limited. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.
What does Oxymetazoline Hydrochloride interact with?
Oxymetazoline may interact with other medications that affect vascular tone or blood pressure.
Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Systemic sympathomimetics (e.g., pseudoephedrine): additive vasoconstrictive effect.
Moderate Interactions (Monitor Closely):\n- Antihypertensive agents: possible reduction in blood‑pressure‑lowering effect. - Tricyclic antidepressants: may enhance vasoconstriction. - Nasal corticosteroids: monitor for increased local irritation.
Frequently asked questions
What is Nesivine Baby Sine Conservans used for?+
How does oxymetazoline work to clear a blocked nose?+
What is the usual dose of Nesivine Baby Sine Conservans?+
Is oxymetazoline safe during pregnancy or breastfeeding?+
How do I order Nesivine Baby Sine Conservans from GNH USA?+
How does oxymetazoline compare with other nasal decongestants?+
What are the storage requirements for Nesivine Baby Sine Conservans?+
How is Nesivine Baby Sine Conservans administered?+
What are the most serious risks associated with oxymetazoline use?+
Who should not use Nesivine Baby Sine Conservans?+
Product details
Related products

Good Sense Nasal .5 mg/mL
Oxymetazoline Hydrochloride · 0.5 mg/mL

Good Sense Nasal .05 g/100mL
Oxymetazoline Hydrochloride · 0.05 g/100 mL

Anefrin Nasal Original .05 g/100mL
Oxymetazoline Hydrochloride · 0.05 g/100 mL

Major Nasal Decongestant .5 mg/mL
Oxymetazoline hydrochloride · 0.5 mg/mL